Multimodality radiotherapy and androgen ablation in the treatment of clinically localized prostate cancer: early results in high risk patients.

Coblentz, T R; Bissonette, E A; Williams, K R; Theodorescu, D

Coblentz, T R; Bissonette, E A; Williams, K R; Theodorescu, D.

Affiliation

Coblentz TR; Department of Urology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.

Prostate Cancer Prostatic Dis ; 5(3): 219-25, 2002.

Article in En | MEDLINE | ID: mdl-12496985

Subject(s)

Androgen Antagonists/therapeutic use; Brachytherapy; Leuprolide/therapeutic use; Prostatic Neoplasms/therapy; Aged; Aged, 80 and over; Combined Modality Therapy; Humans; Male; Middle Aged; Prostate-Specific Antigen/blood; Risk

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Brachytherapy / Leuprolide / Androgen Antagonists Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Prostate Cancer Prostatic Dis Year: 2002 Document type: Article

Search on Google

XML

PubMed Links